Deepening NSF’s innovative analytical testing and product development capabilities, NSF has acquired Cambium Analytica, an analytical testing and development company serving the natural food, beverage, and dietary supplement industries.

The dietary supplement and food testing and development businesses are poised for growth, fueled by evolving consumer priorities around health and wellness, the rise of food as medicine, product development and innovation, and evolving regulations.

With the addition of Cambium Analytica, NSF is now positioned to more fully meet the accelerating demands of clients resulting from these macrotrends, enabling companies to grow demand for natural food, beverage, and supplement products while ensuring safety and quality, particularly in those seeking to innovate in these industries.

Operating as a part of NSF’s largest division, Food and Nutrition—which is led by Sarah Krol, Vice President, Food and Nutrition, NSF—the addition of Cambium Analytica’s capabilities to NSF’s fastest-growing business allow the organization to stay ahead of market trends and client needs, offering a bench of experts in an evolving regulatory environment shaped by global headwinds and powered by greater digitalization and speed.

To fully capture the opportunities created by this acquisition, NSF will work closely with the Cambium Analytica leaders to create a seamless experience for food, beverage, nutrition, and other clients globally.

The acquisition bridges gaps in the natural products market. Cambium’s timely in-process quality assurance (QA) and batch release testing, contract research, and product development services will integrate with NSF’s audit-focused certification programs, offering clients complete support from concept through market compliance.

Cambium Analytica will be renamed Cambium Analytica, an NSF company, and its 69 employees will continue to operate out of its Traverse City, Michigan, headquarters.